Lyt-200 is a humanized monoclonal antibody targeting Galectin-9. Lyt-200 exhibits potent inhibitory effects on hematological cancer cells and can also be used in combination with methotrexate (HY-14519) for research purposes[1].
Molecular Weight:
(145.46 kDa)
Purity:
99.16
Target:
Galectin
Application Notes:
MCE Product type: Inhibitory Antibodies
* VAT and and shipping costs not included. Errors and price changes excepted
